Viewing StudyNCT00313768



Ignite Creation Date: 2024-05-05 @ 4:48 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00313768
Status: TERMINATED
Last Update Posted: 2009-09-28
First Post: 2006-04-10

Brief Title: Randomized Ph 2 Trial Of PaclitaxelCarboplatin Bevacizumab PF-3512676 And PCB Alone In Advanced Nonsquamous NSCLC
Sponsor: Pfizer
Organization: Pfizer

Organization Data

Organization: Pfizer
Class: INDUSTRY
Study ID: A8501003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Pfizer
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Director Clinical Trial Disclosure Group
Old Organization: Pfizer Inc

Collaborators